Iradimed (IRMD) Competitors $51.96 -1.07 (-2.02%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$51.88 -0.08 (-0.15%) As of 05:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IRMD vs. TMDX, LIVN, ENOV, NVCR, LMAT, CNMD, WRBY, CDRE, KMTS, and TNDMShould you be buying Iradimed stock or one of its competitors? The main competitors of Iradimed include TransMedics Group (TMDX), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), CONMED (CNMD), Warby Parker (WRBY), Cadre (CDRE), Kestra Medical Technologies (KMTS), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. Iradimed vs. TransMedics Group LivaNova Enovis NovoCure LeMaitre Vascular CONMED Warby Parker Cadre Kestra Medical Technologies Tandem Diabetes Care Iradimed (NASDAQ:IRMD) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk. Do insiders and institutionals believe in IRMD or TMDX? 92.3% of Iradimed shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 37.1% of Iradimed shares are held by company insiders. Comparatively, 7.0% of TransMedics Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend IRMD or TMDX? Iradimed presently has a consensus price target of $72.00, indicating a potential upside of 38.57%. TransMedics Group has a consensus price target of $122.70, indicating a potential upside of 40.74%. Given TransMedics Group's higher possible upside, analysts clearly believe TransMedics Group is more favorable than Iradimed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iradimed 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.82 Which has more volatility and risk, IRMD or TMDX? Iradimed has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500. Is IRMD or TMDX more profitable? Iradimed has a net margin of 26.26% compared to TransMedics Group's net margin of 8.14%. Iradimed's return on equity of 24.12% beat TransMedics Group's return on equity.Company Net Margins Return on Equity Return on Assets Iradimed26.26% 24.12% 21.20% TransMedics Group 8.14%18.74%4.39% Does the MarketBeat Community believe in IRMD or TMDX? Iradimed received 147 more outperform votes than TransMedics Group when rated by MarketBeat users. Likewise, 65.40% of users gave Iradimed an outperform vote while only 58.95% of users gave TransMedics Group an outperform vote. CompanyUnderperformOutperformIradimedOutperform Votes25965.40% Underperform Votes13734.60% TransMedics GroupOutperform Votes11258.95% Underperform Votes7841.05% Which has stronger valuation and earnings, IRMD or TMDX? Iradimed has higher earnings, but lower revenue than TransMedics Group. Iradimed is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIradimed$73.24M9.02$19.23M$1.5034.64TransMedics Group$441.54M6.65-$25.03M$1.0186.32 Does the media refer more to IRMD or TMDX? In the previous week, TransMedics Group had 38 more articles in the media than Iradimed. MarketBeat recorded 46 mentions for TransMedics Group and 8 mentions for Iradimed. Iradimed's average media sentiment score of 1.45 beat TransMedics Group's score of 0.17 indicating that Iradimed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iradimed 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 12 Very Positive mention(s) 6 Positive mention(s) 24 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral SummaryIradimed beats TransMedics Group on 11 of the 19 factors compared between the two stocks. Remove Ads Get Iradimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRMD vs. The Competition Export to ExcelMetricIradimedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$660.67M$4.07B$5.33B$7.57BDividend Yield1.36%39.49%5.11%4.32%P/E Ratio34.6427.6321.6617.82Price / Sales9.0250.21373.3994.61Price / Cash40.1251.0838.1534.64Price / Book9.185.826.474.00Net Income$19.23M$67.09M$3.20B$247.23M7 Day Performance0.39%-0.17%2.86%1.45%1 Month Performance-0.93%-3.20%-8.56%-6.24%1 Year Performance26.64%14.84%10.58%0.60% Iradimed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRMDIradimed4.8739 of 5 stars$51.96-2.0%$72.00+38.6%+27.1%$660.67M$73.24M34.64110Short Interest ↓Positive NewsGap DownTMDXTransMedics Group2.7684 of 5 stars$69.15+2.2%$122.70+77.4%-5.1%$2.33B$441.54M73.56210LIVNLivaNova3.561 of 5 stars$35.40-1.5%$61.17+72.8%-34.8%$1.92B$1.25B84.292,900Positive NewsHigh Trading VolumeENOVEnovis2.2227 of 5 stars$32.41-0.4%$58.50+80.5%-44.7%$1.85B$2.11B-14.806,800NVCRNovoCure3.335 of 5 stars$16.61+0.7%$35.80+115.5%+29.4%$1.83B$605.22M-11.861,320LMATLeMaitre Vascular3.0974 of 5 stars$79.39-0.5%$95.25+20.0%+31.3%$1.79B$219.86M43.38490Positive NewsHigh Trading VolumeCNMDCONMED4.7109 of 5 stars$55.34-1.6%$77.20+39.5%-35.5%$1.71B$1.31B13.054,100WRBYWarby Parker3.3236 of 5 stars$15.43-2.2%$23.43+51.8%+13.5%$1.60B$771.32M-57.153,491Analyst ForecastPositive NewsGap DownCDRECadre3.4227 of 5 stars$28.30+0.5%$37.00+30.7%-7.8%$1.15B$567.56M34.102,240KMTSKestra Medical TechnologiesN/A$22.78-2.1%$27.67+21.5%N/A$1.13B$45.82M0.00300Earnings ReportQuiet Period ExpirationNews CoverageTNDMTandem Diabetes Care4.2123 of 5 stars$16.85-0.2%$45.38+169.3%-44.4%$1.12B$940.20M-8.732,600News CoveragePositive News Remove Ads Related Companies and Tools Related Companies TMDX Competitors LIVN Competitors ENOV Competitors NVCR Competitors LMAT Competitors CNMD Competitors WRBY Competitors CDRE Competitors KMTS Competitors TNDM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRMD) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Iradimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRMD Stock Free IRMD Stock Alerts